Rachel Gowland, 24 November 2021
Health Education England elearning for healthcare worked in partnership with NHS England and NHS Improvement, Accelerated Access Collaborative, Wessex AHSN Network, and the Office for Life Sciences to develop a new elearning programme, focused on FeNO in Asthma. Although developed for primary care professionals, other healthcare professionals may find the programme useful.
What is FeNO?
FeNO (Fractional exhaled nitric oxide), is a test for measuring the amount of nitric oxide in the exhaled breath of patients. The results of the test can help with the diagnosis of asthma, by showing the level of inflammation in the lungs. A patient’s FeNO level helps improve the accuracy of asthma diagnosis and helps indicate which medications will work best for them.
About the elearning module
This programme aims to improve the learner’s understanding of FeNO, how the test is performed and appropriate language to use when talking about FeNO with patients.
A second FeNO elearning module is being developed and due to be released in December 2021. It focuses on the interpretation of FeNO, providing an enhanced description of what FeNO is and how it can be used in the diagnosis of asthma, with case examples, covering a spectrum of clinical scenarios.
More information
For further details on the AAC FeNO programme, visit the NHS England website.
To access the FeNO deployment toolkit, visit the Wessex ASHN website.
Access the elearning
You can read more about the FeNO elearning module on the programme page.
If you wish to leave feedback on this elearning module, please complete the evaluation survey.
Comments are closed.